US-Based Delphi Consensus Study on Adjuvant Radiation Therapy in Node-Negative Cutaneous Squamous Cell Carcinoma
International Journal of Radiation Oncology*Biology*Physics · 2026-10
DOI: 10.1016/j.ijrobp.2026.09.022 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-10. Verfasst von Jacqueline S Stevens und 35 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: There is a paucity of high-level evidence for adjuvant radiation therapy (ART) in cutaneous squamous cell carcinoma (CSCC), creating practice variations. This study provides expert consensus recommendations on patient and tumor selection, timing, duration, dosage, and additional considerations for ART in node-negative CSCC. METHODS: The Delphi panel included 35 experts in radiation oncology (15), dermatology/Mohs micrographic surgery (9), medical oncology (7), head and neck surgery (3), and surgical oncology (1). Consensus was defined as ≥80% concordance and near-consensus as 70% to 79% concordance. RESULTS: Consensus was reached to recommend ART when further surgery is not possible, but the tumor has positive gross or histologic/microscopic margins (35/35, 100%). Key consensus or near-consensus recommendations for recommending ART to the tumor bed following negative-margin surgery include: 5-year cumulative incidence of local recurrence (29/35, 83%) or nodal metastasis (27/35, 77%) ≥20%; gross cortical bone/marrow invasion (32/35, 91%); skull base invasion (32/35, 91%); 4 risk factors (RFs) (35/35, 100%); 3 RFs (30-33/35, 86%-94%); perineural invasion ≥0.1 mm and one other RF (30/35, 86%); and clinical nerve invasion (31/35, 89%). Immune status influenced ART decision-making (30/35, 86%), with 77% (27/35) more likely to recommend ART for immunosuppressed patients. Consensus was reached to omit ART for pathologic complete response following neoadjuvant immunotherapy (34/35, 97%). Among radiation oncologists, 100% (15/15) agreed that the optimal window for ART to the tumor bed is 4 to 8 weeks, and that hypofractionated regimens can be appropriate (12/15, 80%). Consensus was reached for prescription doses of 60 to 66 Gy in 2 Gy/fx (15/15, 100%) or 50 to 55 Gy in 2.5 Gy/fx (13/15, 87%), and that superficial radiation and brachytherapy are inappropriate ART modalities for node-negative high-stage CSCC (14/15, 93%). There was no consensus on elective nodal basin irradiation. CONCLUSIONS: This Delphi study provides an expert consensus-based framework to standardize ART for node-negative high-stage CSCC following surgery, informing future guidelines and utilization.
Autor:innen und Institutionen
- Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.
- Memorial Sloan Kettering Cancer Center, New York, New York.
- Mount Sinai School of Medicine, New York, New York.
- The Ohio State University College of Medicine, Columbus, Ohio.
- Medical University of South Carolina, Charleston, South Carolina.
- Stanford University, Stanford, California.
Zitieren
APA
Stevens, J. S., Barker, C. A., Bakst, R. L., Bradford, C., Carr, D. R., Chera, B., Chen, M., Chandra, S., Demer, A., Donnelly, H., Doonan, B., Galloway, T. J., Geiger, J., Jambusaria, A., Khushalani, N. I., Koyfman, S., Leitenberger, J. J., Lilley, E., Lukens, J. N., …, & Ruiz, E. S. (2026). US-Based Delphi Consensus Study on Adjuvant Radiation Therapy in Node-Negative Cutaneous Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.09.022
Vancouver
Stevens JS, Barker CA, Bakst RL, Bradford C, Carr DR, Chera B, et al. US-Based Delphi Consensus Study on Adjuvant Radiation Therapy in Node-Negative Cutaneous Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.09.022
BibTeX
@article{Stevens2026,
author = {Stevens, Jacqueline S and Barker, Christopher A and Bakst, Richard L and Bradford, Carol and Carr, David R and Chera, Bhisham and Chen, Michelle and Chandra, Sunandana and Demer, Addison and Donnelly, Heidi and Doonan, Bently and Galloway, Thomas J and Geiger, Jessica and Jambusaria, Anokhi and Khushalani, Nikhil I and Koyfman, Shlomo and Leitenberger, Justin J and Lilley, Elizabeth and Lukens, John Nicholas and Margalit, Danielle and Medina, Theresa and Mitra, Devarati and Muralidhar, Vinayak and Paly, Jonathan and Pashtan, Itai and Patel, Vishal and Sethi, Rosh and Shukla, Monica and Silk, Ann W and Srivastava, Divya and Swiecicki, Paul and Witek, Matthew and Wysong, Ashley and Yom, Sue and Schoenfeld, Jonathan D and Ruiz, Emily S},
title = {US-Based Delphi Consensus Study on Adjuvant Radiation Therapy in Node-Negative Cutaneous Squamous Cell Carcinoma},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
doi = {10.1016/j.ijrobp.2026.09.022}
}
EUVIMED